VEGFA : VEGFR2 [Biotinylated] Inhibitor Screening ELISA Kit

Customer Reviews
Cat. No. / Size
Price
Qty
EP-137-96tests
$770.00
ETA of in-stock products:2 business days

Product Details

  • Materials Provided

    ID
    Components
    Size
    EP137-C01
    High-bind Plate
    1 plate
    EP137-C02
    Human VEGFA
    10 μg
    EP137-C03
    Biotinylated Human VEGFR2
    20 μg
    EP137-C04
    Anti-VEGFA Neutralizing Antibody
    20 μg
    EP137-C05
    Streptavidin-HRP
    10 μg
    EP137-C06
    Coating Buffer
    12 mL
    EP137-C07
    10xWashing Buffer
    50 mL
    EP137-C08
    Blocking Buffer
    50 mL
    EP137-C09
    Substrate Solution
    12 mL
    EP137-C10
    Stop Solution
    7 mL

  • Product Overview

    VEGFA : VEGFR2 [Biotinylated] Inhibitor Screening ELISA Kit is based on a competition-ELISA method, is used to screening for inhibitors of human VEGFA binding to human VEGFR2. The kit is designed to provide a reliable solution for the screening of antibodies and small molecule inhibitors in the early stages, as well as QC release, to help researchers quickly screen and validate drugs, effectively improving research and development efficiency. It can also be used as a universal detection tool to identify the ability of human VEGFA binding to human VEGFR2.

  • Reconstitution

    Please see Certificate of Analysis for details of reconstitution instruction and specific concentration.

  • Storage

    1. Unopened kit should be stored at 2℃-8℃ upon receiving.

    2. Find the expiration date on the outside packaging and do not use reagents past their expiration date.

    3. The opened kit should be stored per components table. The shelf life is 30 days from the date of opening.

  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Customers Also Viewed

Performance Data

  • Typical Data 

    Please refer to DS document for the assay protocol.

     VEGF165 TYPICAL DATA

    INHIBITION OF VEGFA: VEGFR2 [Biotinylated] BINDING BY ANTI-VEGF NEUTRALIZING ANTIBODY
    Serial dilutions of Anti-VEGFA Neutralizing antibody (Catalog # EP137-C04) (1:1 serial dilution, from 10 μg/mL to 0.15625 μg/mL) was added into VEGFA: Biotinylated VEGFR2 binding reactions. The assay was performed according to the protocol described below. Background was subtracted from data points prior to log transformation and curve fitting (QC tested).

Customer Reviews
Writing Reviews

Recent Advances

 
Drug Development Progress
  • English Name:

    Vascular endothelial growth factor A

  • Category:

  • Approved Drugs:

    54 Details

  • Drugs in Clinical Trials:

    61 Details

  • Highest Development Stage:

    Approved

Contact Us
Drug Candidate Licensing
More
  • Basic Product Information
  • Product Details
  • Customers Also Viewed
  • Performance Data
  • Customer Reviews
Contact Us

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8